You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 3, March 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgery
 •Surgery, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Papillary Thyroid Carcinoma

Prognostic Index for Survival Including the Histological Variety

S. Ortiz Sebastian, MD; J. M. Rodríguez Gonzalez, MD; P. Parilla Paricio, MD; J. Sola Perez, MD; D. Pérez Flores, PhD; A. Piñero Madrona, MD; P. Ramirez Romero, MD; F. J. Tebar, MD

Arch Surg. 2000;135:272-277.

Background  Numerous prognostic factors have been studied for survival in patients with papillary thyroid carcinoma (PTC), although there are few multivariate studies that include the histological variety of PTC.

Hypothesis  There are prognostic factors that influence survival in a series of patients with PTC, including the histological variety, and a new prognostic index (PI) for survival can be formulated by accounting for these factors.

Design  A retrospective study.

Setting  A university hospital department of surgery.

Patients  Between January 1970 and December 1995, 200 patients undergoing surgery for PTC were observed (mean follow-up, 8 years).

Main Outcome Measures  A univariate analysis was done for survival rates using the Kaplan-Meier estimation method. The possible prognostic factors were evaluated using a multivariate analysis according to the Cox model. We formulated a PI and defined 3 risk groups (low, medium, and high) for mortality.

Results  Of the 200 patients, 175 (87.5%) are still alive. Of the 25 deaths, 19 (9.5%) were due to the tumor. The survival was 97.5% at 1 year, 92.8% at 5, 89.5% at 10, and 83.9% at 15 and 20 years. The prognostic factors obtained after the multivariate analysis were age, tumor size, extrathyroid spread, and histological variant of the PTC. The PI is calculated as follows: PI = (2 x size) +(6 x spread) + (2 x variant) + (3 x age). As for the risk groups, the low-risk group showed a mortality of 0%; the medium-risk group, 17.1%; and the high-risk group, 76.5%.

Conclusions  The histological variety of PTC has prognostic value for survival in patients with PTC. As risk factors for PTC mortality, we consider an age of 50 years or older, a tumor larger than 4 cm, the existence of extrathyroid spread, and a certain histological subtype of PTC. With these risk factors, it is possible to formulate a PI and classify patients into low-, medium-, and high-risk groups for mortality.


From the Departments of Surgery (Drs Ortiz Sebastian, Rodríguez Gonzalez, Parilla Paricio, Piñero Madrona, and Ramirez Romero), Pathology (Dr Sola Perez), Statistics (Dr Pérez Flores), and Endocrinology (Dr Javier Tebar), Hospital Universitario Virgen de la Arrixaca (Murcia), Servicio de Cirugía General y Aparato Digestivo (I), El Palmar, Murcia, Spain.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(3):375-376.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Simplifying the TNM System for Clinical Use in Differentiated Thyroid Cancer
Onitilo et al.
JCO 2009;27:1872-1878.
ABSTRACT | FULL TEXT  

Thyroid Cancer in Adults
SCOTT
radtech 2009;80:241-261.
ABSTRACT | FULL TEXT  

Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
Lang et al.
Endocr Relat Cancer 2007;14:29-42.
ABSTRACT | FULL TEXT  

Follicular Variant of Papillary Thyroid Carcinoma: A Long-term Follow-up
Passler et al.
Arch Surg 2003;138:1362-1366.
ABSTRACT | FULL TEXT  

Surgical Treatment of Cervical Nodal Metastases in Patients With Papillary Thyroid Carcinoma
Bhattacharyya
Arch Otolaryngol Head Neck Surg 2003;129:1101-1104.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.